Related Experiment Video
Updated: May 14, 2026
06:11
A High-throughput Shigella-specific Bactericidal Assay
Published on: February 27, 2019
Progress and pitfalls in Shigella vaccine research
Eileen M Barry1, Marcela F Pasetti, Marcelo B Sztein
1University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD 21201, USA.
Nature Reviews. Gastroenterology & Hepatology
|February 20, 2013
Summary
Developing new Shigella vaccines is crucial due to high child mortality in developing nations. Recent advances in vaccinology show promise for safe and effective Shigella vaccines, despite ongoing challenges.
Area of Science:
- Microbiology and Immunology
- Vaccinology
- Infectious Diseases
Background:
- Shigella infection causes significant illness and death in young children, particularly in developing countries.
- There is a critical need for effective interventions against Shigella.
Purpose of the Study:
- To review recent progress in the development of Shigella vaccines.
- To discuss the challenges and opportunities in creating safe and effective Shigella vaccines.
Main Methods:
- Review of recent scientific literature on Shigella vaccine development.
- Analysis of advancements in vaccinology and immunological response measurement.
- Examination of clinical trial data for existing and novel vaccine candidates.
Main Results:
- Significant progress has been made in developing novel Shigella vaccine strategies.
- Technological innovations have accelerated vaccine development.
- New data on immunological responses are available.
Conclusions:
- The development of safe and effective Shigella vaccines is increasingly promising.
- Continued research and development are needed to overcome persistent obstacles.
- Novel vaccine strategies offer hope for reducing Shigella-related morbidity and mortality.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...